Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Part of paid clinical trials in Arvada, Colorado.
- Sponsor
- Kardigan, Inc.
- Study ID
- NCT07511361
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Acute Severe Hypertension
- Hypertension
- Hypertensive Emergency
- Hypertensive Urgency
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tonlamarsen — DRUGTonlamarsen will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
- Placebo — DRUGPlacebo will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
Study Details
The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
Key Dates
- First listed
- Apr 6, 2026
- Start date
- Jun 23, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2026
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 140 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Tonlamarsen3 doses active drug will be administered by subcutaneous (under the skin) injection (one dose every 4 weeks)
- Placebo Comparator: Placebo3 doses of placebo will be administered by subcutaneous (under the skin) injection (one dose every 4 weeks)
Primary Outcome Measure
Part A: To assess variability in clinical and biomarker measures to inform Part B sample-size estimation and study-design assumptions [ Time Frame: Baseline through Week 12 ]
Central Contacts
- Kardigan Clinical Study Information Team+1-877-310-5135
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Western Nephrology and Metabolic Bone Disease, PC - Arvada | Arvada | Colorado | 80002 | |
| Homestead Associates in Research | Homestead | Florida | 33033 | |
| Progressive Medical Research | Port Orange | Florida | 32127 | |
| Richmond University Medical Center (RUMC) | Staten Island | New York | 10310 | |
| Research Innovations, LLC | Beavercreek | Ohio | 05431 | |
| Chattanooga Research & Medicine CHARM | Chattanooga | Tennessee | 37404 | |
| Laguna Clinical Research Associates | Laredo | Texas | 78041 | |
| Baylor Scott and White Research Institute - Temple | Temple | Texas | 76502 |
Find similar trials in Arvada, CO
By condition
By specialty
By research site
Western Nephrology and Metabolic Bone Disease, PC - Arvada· Arvada, COHomestead Associates in Research· Homestead, FLProgressive Medical Research· Port Orange, FLRichmond University Medical Center (RUMC)· Staten Island, NYResearch Innovations, LLC· Beavercreek, OHChattanooga Research & Medicine CHARM· Chattanooga, TN
Related Studies
- Metabolic Effects of Angiotensin-(1-7)PHASE1 · Recruiting · Vanderbilt University · Nashville, Tennessee
- Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine HypertensionRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older AdultsPHASE2 · Recruiting · Douglas Seals · Boulder, Colorado